ctrl K

Watchlist Price Alert

Gain Therapeutics Inc. (GANX)

NASDAQ: GANX · Real-Time Price · USD

1.79

0.02 (1.13%)

At close: May 28, 2025, 3:59 PM

1.85

3.06%

After-hours: May 28, 2025, 04:05 PM EDT

Gain Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	55.18K	140.11K	164.99K	28.88K	41.3K	20.61K
Cost of Revenue	84.07K	80.38K	64.17K	7.16M	2.26M	n/a	n/a
Gross Profit	n/a	-25.2K	75.94K	-7M	-2.23M	41.3K	20.61K
Operating Income	-20.35M	-22.25M	-17.78M	-13.83M	-3.48M	-2.1M	-1.03M
Interest Income	n/a	494.23K	375.36K	12.49K	3.64K	20.54K	n/a
Pretax Income	-19.87M	-22.19M	-17.5M	-13.89M	-3.57M	-2.19M	-1.1M
Net Income	-20.41M	-22.27M	-17.59M	-13.89M	-3.58M	-2.19M	-1.11M
Selling & General & Admin	9.56M	10.79M	9.54M	6.83M	1.25M	555.16K	222.05K
Research & Development	10.79M	11.52M	8.38M	7.16M	2.26M	1.59M	826.88K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	20.35M	22.31M	17.92M	13.99M	3.51M	2.14M	1.05M
Interest Expense	n/a	n/a	n/a	n/a	n/a	20.54K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	-20.35M	22.31M	17.92M	13.99M	3.51M	2.14M	1.05M
Income Tax Expense	536.82K	79.28K	92.98K	4.01K	5.39K	7.11K	9.78K
Shares Outstanding (Basic)	22.88M	13.01M	11.88M	10.17M	11.88M	11.88M	5.86M
Shares Outstanding (Diluted)	22.88M	13.01M	11.88M	10.17M	11.88M	11.88M	5.86M
EPS (Basic)	-0.89	-1.71	-1.48	-1.37	-0.3	-0.18	-0.19
EPS (Diluted)	-0.89	-1.71	-1.48	-1.37	-0.3	-0.18	-0.19
EBITDA	-19.79M	-22.17M	-17.78M	-13.82M	-3.47M	-2.1M	-1.03M
EBIT	-19.87M	-22.25M	-17.78M	-13.83M	-3.48M	-2.1M	-1.03M
Depreciation & Amortization	84.07K	83.58K	64.17K	15.48K	9.59K	2.57K	741.00